Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SKQ1 (bromide) is a mitochondria-targeted antioxidant that decreases transmembrane potential and production of reactive oxygen species (ROS).1 SKQ1 prevents neuronal loss and synaptic damage in a rat model of spontaneous Alzheimer’s disease, as well as decreases severity of arthritic lesions in rats.2,3 SKQ1 slows development of age-related ocular pathologies in murine, porcine, bovine, and canine model systems.4 It also prevents acute phenoptosis following rhabdomyolysis, stroke, and myocardial infarction.5,6,7
WARNING This product is not for human or veterinary use.
1. Cationic antioxidants as a powerful tool against mitochondrial oxidative stress. Biochem. Biophys. Res. Commun. 441(2), 275-279 (2013).
2. An antioxidant specifically targeting mitochondria delays progression of Alzheimer’s disease-
3. Efficacy of mitochondrial antioxidant plastoquinonyl-
4. Receptor regulation of senile phenoptosis. Biochemistry (Mosc.) 79(10), 994-1003 (2014).
5. Mechanisms of nephroprotective effect of mitochondria-
6. Protective effect of mitochondria-
7. An attempt to prevent senescence: A mitochondrial approach. Biochim. Biophys. Acta 1787(5), 437-461 (2009).
Scaffolding LSD1 inhibitors impair NK cell metabolism and cytotoxic function through depletion of glutathione. Front. Immunol. 11, 2196 (2020).